Clinical evidence of semaglutide for metabolic dysfunction‐associated steatotic liver disease (MASLD): An updated meta‐analysis.
Saved in:
| Title: | Clinical evidence of semaglutide for metabolic dysfunction‐associated steatotic liver disease (MASLD): An updated meta‐analysis. |
|---|---|
| Authors: | Peng, Tzu‐Rong1,2,3 (AUTHOR), Lin, Hung‐Hong4 (AUTHOR), Tseng, Tzu‐Ling3,5,6 (AUTHOR), Wu, Ta‐Wei1,7 (AUTHOR) chaoycmd@yahoo.com.tw, Chao, You‐Chen8,9 (AUTHOR) chaoycmd@yahoo.com.tw |
| Source: | British Journal of Clinical Pharmacology. Jun2026, p1. 10p. 10 Illustrations. |
| Database: | Academic Search Ultimate |
| ISSN: | 03065251 |
|---|---|
| DOI: | 10.1002/bcp.70629 |
